Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention

NCT00818753 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Catheterization

Interventions

DRUG: dabigatran 110 mg
DRUG: dabigatran 150 mg
DRUG: unfractionated heparin

Sponsor

Boehringer Ingelheim